Latest Australian Government News

Augustus Minerals reveals encouraging molybdenum and copper intersections from deep diamond drilling at Minnie Springs, highlighting promising mineralisation trends within its Ti-Tree Project.

VanEck Investments Limited has announced final dividends for a suite of its Australian and global bond ETFs, with payments scheduled for mid-February 2025. Investors are advised to note the ex-dividend dates and dividend reinvestment plan details.

GreenHy2 Limited reports a slight cash decline but strengthens its foothold in renewable energy with key partnerships and strategic pivots in hydrogen storage technology.

Optiscan Imaging Ltd has secured a $1.775 million R&D tax refund for FY24, more than doubling last year’s amount thanks to expanded claims on overseas research. The boost will fund ongoing development of its cutting-edge confocal laser endomicroscopy technology.

Dalaroo Metals advances its Lyons River Project with promising diamond drilling results confirming Broken Hill Type mineralisation and reports high-grade copper assays. The company also appoints Michael Brown as new MD and CEO, signaling a strategic push forward.

Matsa Resources is poised to commence mining at its Devon Pit Gold Mine after securing all regulatory approvals and raising fresh capital. The company targets delivering its final feasibility study in the March 2025 quarter, marking a critical step toward production.

Neurotech International has secured a $2.44 million R&D tax incentive refund, strengthening its cash position as it advances clinical trials for paediatric neurological disorders and prepares for regulatory submissions in FY2025.

Premier1 Lithium's latest quarterly report reveals multiple high-grade gold assay results at its Yalgoo Project and a successful $1.5 million capital raise, setting the stage for imminent drilling activities.

Orbital Corporation Ltd reports a strong quarterly update with 29 engines delivered, a debt-free balance sheet, and significant R&D grant funding supporting new engine development.

Zenith Minerals reported a 40% increase in its Dulcie Far North gold resource and secured A$2.48 million in new funding, positioning the company for aggressive exploration across its Australian gold and lithium projects.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.

NH3 Clean Energy has made significant strides in its WAH2 Project, finalising critical commercial agreements and progressing technical work ahead of Front End Engineering and Design (FEED) entry scheduled for Q1 2025. The company also completed a capital raise to support these developments.